Description of use

For use with digitized H&E stained breast biopsy & excision tissues. CLEO BREAST employs AI-based algorithms to assist pathologists in their diagnostic journey, integrating AI-enhanced tools including to detect the presence of critical biomarkers, such as Invasive Carcinoma, Metastases, Mitoses, Calcifications and Emboli. By incorporating these models, CLEO BREAST not only streamlines the diagnostic process but also heightens its precision. This robust approach aids pathologists in elevating diagnostic accuracy, curtailing turnaround times, and optimizing lab efficiency. The pathologist has to review the results of CLEO BREAST and is responsible for the final diagnosis.